EFAA.US Invesco MSCI EAFE Income Advantage ETF
- Total assets
- 681M
- Expense ratio
- 0.38%
- Dividend yield
- 8.38%
- 1-year return
- +10.90%
- Holdings
- 652
- Since
- 2024
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does EFAA.US invest in?
- Mostly Non-US stocks (75.5%)
- Largest sector: Financial Services (26.2%)
- Largest region: Europe Developed (51.2%)
- Top 3 holdings: 4.5% of the fund
Asset allocation
- Non-US stocks 75.5%
- Cash 24.1%
- US stocks 1.1%
- Other 0.1%
Top holdings
- ASML Holding N.V. 2.13%
- Roche Holding AG 1.25%
- HSBC Holdings PLC 1.09%
- Novartis AG 1.01%
- AstraZeneca PLC 0.99%
Invesco MSCI EAFE Income Advantage ETF performance
Sharpe ratio 0.00- This year
- +8.61%
- 1 year
- +10.90%
- 3 years
- -
- 5 years
- -
Volatility 11.1% over 1 year. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
EFAA.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Invesco MSCI EAFE Income Advantage ETF
The fund seeks to achieve its investment objective by: (1) investing in a portfolio of equity securities, including depositary receipts, designed to track the performance, before fees and expenses, of the MSCI EAFE Index or U.S.-listed exchange-traded funds (ETFs) that seek to track the performance of the index, or both, and (2) utilizing an options-based income strategy implemented through equity-linked notes (ELNs) with exposure to either the index or ETFs tracking the ind…
Full fund profileInvesco MSCI EAFE Income Advantage ETF top holdings
10.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| ASML Holding N.V. ASML.AS | Technology | Netherlands | 2.13% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 1.25% |
| HSBC Holdings PLC HSBA.LSE | Financial Services | United Kingdom | 1.09% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 1.01% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 0.99% |
| Shell plc SHEL.LSE | Energy | United Kingdom | 0.98% |
| Nestle S.A. NESN.SW | Consumer Defensive | Switzerland | 0.96% |
| SAP SE SAP.XETRA | Technology | Germany | 0.85% |
| Mitsubishi UFJ Financial Group Inc 8306.TSE | Financial Services | Japan | 0.84% |
| Siemens Aktiengesellschaft SIE.XETRA | Industrials | Germany | 0.74% |
The 10 largest of 652 holdings.
EFAA.US sector exposure
- Financial Services26.2%
- Industrials19.0%
- Healthcare11.9%
- Technology10.8%
- Consumer Cyclicals7.4%
- Consumer Defensive6.9%
- Basic Materials5.8%
- Communication Services4.7%
- Energy4.0%
- Utilities3.8%
- Real Estate1.6%
Share of the stocks in the fund.
EFAA.US regional exposure
- Europe Developed51.2%
- Japan24.1%
- United Kingdom14.1%
- Australasia6.9%
- Asia Developed3.6%
- North America1.5%
- Africa/Middle East1.0%
- Asia Emerging0.2%
- Latin America0.1%
Share of the stocks in the fund.
Company size
Average market cap 73.1B- Mega cap39.9%
- Big cap28.4%
- Medium cap6.6%
- Small cap0.1%
Invesco MSCI EAFE Income Advantage ETF fund profile
- Fund name
- Invesco MSCI EAFE Income Advantage ETF
- Ticker
- EFAA.US
- Exchange
- USA Stocks
- Issuer
- Invesco
- Index tracked
- -
- Category
- -
- Inception date
- Jul 17, 2024
- Trading currency
- USD
- Expense ratio
- 0.38%
About Invesco MSCI EAFE Income Advantage ETF
The fund seeks to achieve its investment objective by: (1) investing in a portfolio of equity securities, including depositary receipts, designed to track the performance, before fees and expenses, of the MSCI EAFE Index or U.S.-listed exchange-traded funds (ETFs) that seek to track the performance of the index, or both, and (2) utilizing an options-based income strategy implemented through equity-linked notes (ELNs) with exposure to either the index or ETFs tracking the index. The fund is non-diversified.